Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer

PURPOSE: Circulating tumor DNA (ctDNA) is emerging as a valuable non-invasive tool to identify tumor heterogeneity and tumor burden. This study investigated ctDNA dynamics in metastatic colorectal cancer patients treated with regorafenib. MATERIALS AND METHODS: In this prospective biomarker study, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dae-Won, Lim, Yoojoo, Kim, Hwang-Phill, Kim, Su Yeon, Roh, Hanseong, Kang, Jun-Kyu, Lee, Kyung-Hun, Kim, Min Jung, Ryoo, Seung-Bum, Park, Ji Won, Jeong, Seung-Yong, Park, Kyu Joo, Kang, Gyeong Hoon, Han, Sae-Won, Kim, Tae-You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372591/
https://www.ncbi.nlm.nih.gov/pubmed/36915247
http://dx.doi.org/10.4143/crt.2023.268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372591/
https://www.ncbi.nlm.nih.gov/pubmed/36915247
http://dx.doi.org/10.4143/crt.2023.268

Ejemplares similares